Skip to main content

Pharma News

 

Clinical courses

 

Clinical courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Budget 2022 disallows Pharma companies to claim tax cut on freebies to doctors

    Budget 2022 disallows pharmaceutical companies to claim tax cut on freebies to doctors under section 37 of the act. It simply means such expenditure can not be claimed as business deduction, and it will be counted as taxable profit of pharmaceutical industries.

  • Robot performs first laparoscopic surgery without human help

    A robot has performed laparoscopic surgery on the soft tissue of a pig without the guiding hand of a human a significant step toward fully automated surgery on humans. Designed by a team of Johns Hopkins University researchers, the Smart Tissue Autonomous Robot, or STAR, is described today in Science Robotics.

  • Mankind Pharma to buy domestic business of Panacea Biotec Pharma

    Mankind Pharma to buy domestic business of Panacea Biotec Pharma. Both companies entered into an agreement to buy the domestic formulations business of Panacea Biotec Pharma, a subsidiary of Sputnik V maker Panacea Biotec for Rs 1,908 crore.

  • Technology is kept as center point in Healthcare Budget 2022

    Technology has taken a centre-stage for the Health Sector in the General Budget presented in the Parliament by Smt Nirmala Sitharaman, Union Minister of Finance. Two new digitally underpinned Schemes have been announced which indicate the key role that digital technology is playing in expanding the access of health and medical care across the country.

  • Simplified antibiotic may set the stage for antitumor treatments

    Garden soil houses a variety of bacteria and their natural byproducts - including one that may help halt tumor growth. Lankacidins are molecules that can be isolated from Strepomyces rochei, a common bacterium in soil. In addition to antimicrobial properties, a type of lankacidins, called lankacidin C, can inhibit tumor activity in various cancer cell lines, including leukemia, melanoma, ovarian and breast cancers.

  • Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

    Valneva SE a specialty vaccine company, today announced the initiation of a Phase 3 trial in adolescents for its single-shot chikungunya vaccine candidate, VLA1553.

  • CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe asthma with type 2 inflammation

    The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending to extend the approval of Dupixent® (dupilumab) in the European Union (EU) to include add-on maintenance treatment for children aged 6 to 11 years with severe asthma with type 2 inflammation characterized by raised blood eosinophils and/or raised fractional exhaled nitric oxide (FeNO) who are inadequately controlled on two maintenance therapies.

  • Artificial Intelligence and Digital Medicine are critical to future healthcare

    Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said here that Artificial Intelligence (AI) and Digital Medicine are critical to future healthcare.

  • Research and Innovation is a necessity for the sustained growth of the pharmaceuticals sector, says Mansukh Mandaviya

    Union Minister for Chemicals and Fertilizers Shri Mansukh Mandaviya launched NIPER Research Portal along with Shri Bhagwanth Khuba, Minister of State for Chemicals and Fertilizers in presence of Dr V. K Paul, Member (Health), Niti Aayog. National Institute of Pharmaceutical Education and Research (NIPER) Research Portal has been created with the aim to disseminate the information about all the NIPERs and their research activities, patents filed and Publication information at one place so that a industry and other stakeholders know about them.

  • NHM, Tata Steel and AIF to Improve Access to Maternal and Neonatal Care in Jharkhand

    An Engagement Coordination and Arrangement (ECA) on Maternal, Adolescent, Child care and Nutrition in Kolhan division in Jharkhand between National Health Mission, Tata Steel Foundation and American India Foundation under the flagship project MANSI+ (Maternal and Neonatal Survival Initiative+) was signed today at the office of National Health Mission (NHM), Ranchi.

Subscribe to Pharma News